Dr. Rutgers Compares ART or ALND in Breast Cancer

Video

Emiel J. Rutgers, MD, surgical oncologist, Netherlands Cancer Institute, Amsterdam, discusses a study analyzing radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients.

Emiel J. Rutgers, MD, surgical oncologist, Netherlands Cancer Institute, Amsterdam, discusses a study comparing the effectiveness of axillary radiotherapy (ART) and axillary lymph node dissection (ALND) for women with early-stage sentinel lymph node-positive breast cancer.

In the study, 4806 patients with primary tumors up to 5 cm that were clinically node-negative (cT1-2N0) underwent sentinel node biopsies. Depending upon biopsy results, patients received follow-up monitoring or were randomized to ART or ALND.

Rutgers says that after a five-year follow-up period, the rates of cancer recurrence in the axilla were very low for both groups. The recurrence rate in the ART group was 1.03% (7 patients), compared with 0.54% (4 patients) in the ALND group. Oncologically, both treatment strategies are acceptable, Rutgers says.

Read more about this study >>>

<<<

View more from the 2013 ASCO Annual Meeting

Related Videos
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD
Elias Jabbour, MD
Shruti Tiwari, MD
Video 5 - "AE Management with CDK4/6 Inhibitors: Strategies for Treatment Continuity and Optimal Patient Outcomes"
Jeffrey P. Townsend, PhD
Marina Baretti, MD
George R. Simon, MD, FACP, FCCP
Saad Z. Usmani, MD, MBA, FACP, FASCO